Search Results - "Tsirikos, Georgios"

Tocilizumab improves 28-day survival in hospitalized patients with severe COVID-19: an open label, prospective study by Karampitsakos, Theodoros, Malakounidou, Elli, Papaioannou, Ourania, Dimakopoulou, Vasilina, Zarkadi, Eirini, Katsaras, Matthaios, Tsiri, Panagiota, Tsirikos, Georgios, Georgiopoulou, Vasiliki, Oikonomou, Ioanna, Davoulos, Christos, Velissaris, Dimitrios, Sampsonas, Fotios, Marangos, Markos, Akinosoglou, Karolina, Tzouvelekis, Argyris

“…Data on the safety and efficacy profile of tocilizumab in patients with severe COVID-19 needs to be enriched. In this open label, prospective study, we…”
Get full text

Clinical features and outcomes of patients with myositis associated-interstitial lung disease by Karampitsakos, Theodoros, Tzilas, Vasilios, Papaioannou, Ourania, Chrysikos, Serafeim, Vasarmidi, Eirini, Juge, Pierre-Antoine, Vizirianaki, Styliani, Bibaki, Eleni, Reppa, Argyro, Sidiropoulos, Prodromos, Katsaras, Matthaios, Sotiropoulou, Vasilina, Tsiri, Panagiota, Koulousousa, Electra, Theochari, Eva, Tsirikos, Georgios, Christopoulos, Ioannis, Malakounidou, Elli, Zarkadi, Eirini, Sampsonas, Fotios, Hillas, Georgios, Karageorgas, Theofanis, Daoussis, Dimitrios, Kalogeropoulou, Christina, Dimakou, Katerina, Tzanakis, Nikolaos, Borie, Raphael, Dieudé, Philippe, Antoniou, Katerina, Crestani, Bruno, Bouros, Demosthenes, Tzouvelekis, Argyris

“…Myositis associated interstitial lung disease (ILD) seems to be an under-recognized entity. In this multicenter, retrospective study, we recorded between…”
Get full text

Tocilizumab versus baricitinib in hospitalized patients with severe COVID-19: an open label, randomized controlled trial by Karampitsakos, Theodoros, Papaioannou, Ourania, Tsiri, Panagiota, Katsaras, Matthaios, Katsimpris, Andreas, Kalogeropoulos, Andreas P, Malakounidou, Elli, Zarkadi, Eirini, Tsirikos, Georgios, Georgiopoulou, Vasiliki, Sotiropoulou, Vasilina, Koulousousa, Electra, Chourpiliadi, Charikleia, Matsioulas, Apostolos, Lagadinou, Maria, Sampsonas, Fotios, Akinosoglou, Karolina, Marangos, Markos, Tzouvelekis, Argyris

“…Randomized controlled trials comparing tocilizumab and baricitinib in patients with coronavirus disease 2019 (COVID-19) are needed. This was an open-label,…”
Get more information

Safety and Effectiveness of Mycophenolate Mofetil in Interstitial Lung Diseases: Insights from a Machine Learning Radiographic Model by Karampitsakos, Theodoros, Kalogeropoulou, Christina, Tzilas, Vasilios, Papaioannou, Ourania, Kazantzi, Alexandra, Koukaki, Evangelia, Katsaras, Matthaios, Bouros, Evangelos, Tsiri, Panagiota, Tsirikos, Georgios, Zarkadi, Eirini, Ntoulias, Nikolaos, Sotiropoulou, Vasilina, Efthymiou, Panagiotis, Chrysikos, Serafeim, Malakounidou, Elli, Sampsonas, Fotios, Bouros, Demosthenes, Tzouvelekis, Argyrios

“…Treatment of interstitial lung diseases (ILDs) other than idiopathic pulmonary fibrosis (IPF) often includes systemic corticosteroids. Use of steroid-sparing…”
Get more information